Spirulan from blue-green algae inhibits fibrin and blood clots: its potent antithrombotic effects

J Biochem Mol Toxicol. 2015 May;29(5):240-8. doi: 10.1002/jbt.21690. Epub 2015 Feb 4.

Abstract

We investigated in vitro and in vivo fibrinolytic and antithrombotic activity of spirulan and analyzed its partial biochemical properties. Spirulan, a sulfated polysaccharide from the blue-green alga Arthrospira platensis, exhibits antithrombotic potency. Spirulan showed a strong fibrin zymogram lysis band corresponding to its molecular mass. It specifically cleaved Aα and Bβ, the major chains of fibrinogen. Spirulan directly decreased the activity of thrombin and factor X activated (FXa), procoagulant proteins. In vitro assays using human fibrin and mouse blood clots showed fibrinolytic and hemolytic activities of spirulan. Spirulan (2 mg/kg) showed antithrombotic effects in the ferric chloride (FeCl3 )-induced carotid arterial thrombus model and collagen and epinephrine-induced pulmonary thromboembolism mouse model. These results may be attributable to the prevention of thrombus formation and partial lysis of thrombus. Therefore, we suggest that spirulan may be a potential antithrombotic agent for thrombosis-related diseases.

Keywords: Arthrospira platensis; Fibrinolytic activity; Spirulan; anti-procoagulant protein activity; antithrombotic activity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Coagulation / drug effects*
  • Cyanobacteria / chemistry
  • Fibrin / antagonists & inhibitors*
  • Fibrinogen / antagonists & inhibitors
  • Fibrinolytic Agents / chemistry
  • Fibrinolytic Agents / pharmacology*
  • Humans
  • Mice
  • Polysaccharides / chemistry
  • Polysaccharides / pharmacology*
  • Thrombosis / drug therapy*
  • Thrombosis / pathology

Substances

  • Fibrinolytic Agents
  • Polysaccharides
  • spirulan
  • Fibrin
  • Fibrinogen